FDA ties with Gates Foundation
A collaboration between US drug regulator and the Gates Foundation has raised concerns about undue influence over the regulation of pandemic countermeasures.
In 2017, the US Food and Drug Administration (FDA) entered into a memorandum of understanding (MOU) with the Bill & Melinda Gates Foundation.
Under the MOU, the two entities agreed to share information to “facilitate the development of innovative products, including medical countermeasures,” such as diagnostics, vaccines, and therapeutics to combat disease transmission during a pandemic.
The FDA has MOUs with many academic and non-profit organisations, but few have as much to gain as Bill Gates, who has invested billions into pandemic countermeasures.
Experts are concerned the Gates Foundation could have undue influence over the FDA’s regulatory decisions of these countermeasures.